Securus Technologies Acquires JPay Company

Securus Technologies is a paramount technology company that seeks to become part of the solution to the technical problems facing the inmate industry in and out of the United States. For the company, they have always stays in the first position in developing the state-of-the-art technology solutions in the industry. This explains why their services have been adopted on a massive scale among the inmate facilities based in North America. For Securus Technologies, their main aim is to modernize the inmate experience so that the facilities will have minimal time and work to administer justice solutions when needed.

 

Securus Technologies’ management has appended a signature binding their stock purchase agreement form to purchase the Florida-based JPay Company. JPay Company is a digitized payment company that offers digital payment solutions to the inmates. JPay Company serves more than 27 correctional facilities in the United States. While this is true, the company is seeking better business advancement solutions to achieve their intended goals in the industry. JPay has also majored in digital entertainment solutions for most of their achievements in a way that accelerates better business capabilities.

 

Securus Technologies and JPay Company are set to combine in the closest bond of all when the acquisition is complete. The acquisition will also render Securus Technologies as one of the fastest growing companies in the United States. Perhaps this is the reason why they are looking forward to administering achievement solutions in the industry. According to the Securus Technologies management, this acquisition will open doors for the company to start securing better technology deals in the industry. According to the latest statistics, Securus Technologies is second to none when it comes to technology solutions in the business world. This is why most correctional facilities are seeking their services in a way that sets them apart.

 

Will Eric Lefkofsky Improve Cancer Diagnosis And Treatment Through Tempus?

It is certain that Cancer is still a dilemma and continues to affect millions of people worldwide. However, the last decade has seen remarkable progress in the fight against cancer. Researchers have discovered new cancer treatments and therapies. Governments have also joined the fight and are coming up with new policies and regulations that are aimed at stemming the tide of this devastating disease worldwide. There are innovative programs, initiatives, and strategies that have been formed to help accelerate current and future developments against cancer. New companies are also coming up and are changing the way we treat cancer. One such company is Tempus, a revolutionary technology company that has built an innovative operating system that will bring a smart approach in the fight against cancer.

About Tempus

Tempus was founded in 2015 by renowned tech figures, Eric Lefkofsky and Brad Keywell. The company focuses on collecting, analyzing, and storing of large clinical data, which, according to the company’s website, will help doctors make real time, individualized, and data-driven decisions. The duo says that the start-up uses sophisticated genomic sequencing and data analysis techniques that will help come up with the next breakthrough developments in the battle against cancer.

The company works with patients who have lung, pancreatic, and breast cancer and hopes to focus on other forms of cancer over time. The innovative start-up also expects to collaborate with researchers, cancer programs, and hospitals to collect more accurate data and make their system more efficient. They recently announced that they would work with hospitals such as Northwestern’s Lurie Cancer Center, Cleveland Clinic, University of Michigan, Duke University School of Medicine, and other community cancer clinics across the country.

Eric Lefkofsky

Eric Lefkofsky is an influential American entrepreneur. He is Co-founder and the current CEO of Tempus. He is also the man behind Lightbank, a Chicago-based venture capital firm that bets on emerging and disruptive start-ups. Lefkofsky contribution in the fight against cancer did not start at Tempus; he and his wife, Elizabeth, have been making large donations to help cancer researchers come up with technologies and treatments options that can help eradicate cancer.

Thanks to his leadership skills and years of experience, the exceptional leader has been able to transform Tempus from a weak start-up into an invincible force in the medical world. The company is currently valued $700 million.

To Learn More Click Here